Skip to main content
. Author manuscript; available in PMC: 2015 Mar 9.
Published in final edited form as: Biol Blood Marrow Transplant. 2009 Apr 8;15(6):718–723. doi: 10.1016/j.bbmt.2009.02.011

Table 1.

Patient Characteristics (n = 302)

Characteristic Number (%)
Age
Median (range) 58.5 (38–76)
Sex
Men 185 (61)
Women 117 (39)
Isotype
IgG 177 (59)
IgA 63 (21)
Light chain only 47 (15)
Other (IgD, IgM, Nonsecretory) 15 (5)
Durie-Salmon stage at diagnosis
I 59 (20)
II 127 (42)
III 103 (34)
Unknown 13 (4)
No. of previous treatment regimens
1 186 (62)
>1 115 (38)
Interval from diagnosis to mobilization
≤12 months 237 (78)
>12 months 65 (22)
Prior lenalidomide
Yes 64 (21)
No 238 (79)